Author: Biotech Express

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

US pharmaceutical company Pfizer has sought fast-track approval for its vaccine in India. It is in talks with the Centre to roll out 5 crore doses between July and October this year, while asking for significant regulatory relaxations, according to PTI. It has told the government that the vaccine was suitable for everyone aged 12 years or older, and more importantly, can be safely stored for a month at 2 to 8 degrees Celsius. Pfizer has told the government its COVID vaccine shows “high effectiveness” against the India-dominant variant of the virus.  It is ready to roll out five crore doses…

Read More

Pharmaceutical companies Cipla and Roche India on Monday announced the launch of a coronavirus antibody drug cocktail to treat non-hospitalised patients who face high risks of their infections turning severe. The high-risk category includes patients above the age of 60, and those suffering from co-morbidities like diabetes and heart, liver and kidney ailments. The drug, which will come in packs of two doses, will cost Rs 59,750 per dose for the treatment of patients with mild to moderate symptoms, PTI reported. The drug, which has been developed by New York-based Regeneron Pharmaceuticals, will be imported in India by Roche Pharma and marketed…

Read More

Updated on 28 May, 2021 Following the controversial statement on allopathy, the Indian Medical Association’s offensive stance against Swami Ramdev continues. After complaints from the PMM and defamation case of 1000 crores, a complaint has been lodged against them in Delhi as well. A controversial video has surfaced of Baba’s in which yoga gurus react to the ongoing ‘Arrest Ramdev’ trend on social media, saying that ”Unka baap bhi arrest nahi kar sakta”. On behalf of the IMA, the Secretary-General, Dr. Jayesh Lele has filed this complaint. In the complaint given in Delhi’s IP State Police Station, IMA said that Swami Ramdev is raising…

Read More

Kamal Pratap Singh Pfizer eyes $26B in COVID-19 vaccine sales for the year 2021, with $3.5B (360 crore Rs) already in the bag. Moderna has predicted output of up to 1 billion doses this year. Adar Poonawalla on May 1 announced that the Serum Institute would be able to raise its monthly output to 100 million (10 crore) doses by July. India approved Russian made Sputnik V also, and is also planning to approve vaccines made by Pfizer, Moderna, Johnson & Johnson and others. Pfizer is making 300 crore doses (3 billion) whereas Indian vaccine manufacturer consortium of Bharat Biotech…

Read More

Seema Pavgi Upadhye Viruses constantly change through mutation, and new variants of a virus are expected to occur over time. Sometimes new variants emerge and disappear. Other times, new variants emerge and persist. In 2019 when SARS-CoV-2 burst upon the world, scientists knew that it was bad but thought it was stable as Corona Virus don’t mutate as readily as few other viruses like hepatitis, flu or AIDS. Coronaviruses are named for the crown-like spikes on their surfaces. They have a molecular “proof reading “ system that SARS-CoV-2 and its generation use to prevent damaging genetic errors when replicating. But…

Read More

KC Bansal1, Kutubuddin A. Molla2, and Sonia Goel3 1 The Alliance of Bioversity International and CIAT, Asia, India, New Delhi 2 ICAR-National Rice Research Institute, Cuttack 3 SGT University, Gurugram Corresponding Author: kcbansal27@gmail.com Genome or gene editing mediated by CRISPR-Cas system has emerged as a powerful tool with a capability of precisely mutagenizing the genome of a wide range of organisms. The technology is based on an existing bacterial immune system, and is accepted and applied world-wide as a simple, precise and efficient method to genetically improve living organisms including animal and plant species for agriculture, food and nutrition.In…

Read More

Shrikant Nema1, 2 1Division of Vector-Borne Diseases, ICMR-National Institute of Research in Tribal Health, PO Garha, Nagpur Road, Jabalpur-482003, M.P., India; 2School of Biotechnology, Rajiv Gandhi Proudyogiki Vishwavidhalya (State Technological University of Madhya Pradesh), Bhopal, 462 023, Madhya Pradesh, India Correspondence: shrikantnema2014@gmail.com Abstract India along with 25 other countries has set the goal of malaria elimination by 2030. Out of these 26 countries, 22 are affected with COVID-19. We propose herewith that such countries, e.g., India must plan and manage the COVID-19 situations in a way not to hinder targeted malaria elimination goal. Keywords: COVID-19, Malaria elimination, India …

Read More

Union defence minister Rajnath Singh today released the first batch of the anti-Covid-19 drug, 2-deoxy-D-glucose (2-DG), which has been granted emergency approval by the Drug Controller General of India (DCGI). The anti-Covid oral drug has been developed by the Defence Research and Development Organisation’s (DRDO’s) leading laboratory — Institute of Nuclear Medicine and Allied Sciences (INMAS) — in collaboration with Dr Reddy’s Laboratories. Releasing the drug along with Health Minister Harsh Vardhan, Defence Minister Rajnath Singh said 2-deoxy-D-glucose (2-DG) has brought a “new ray of hope” in the treatment of COVID-19 patients. The Drugs Controller General of India (DGCI) approved 2-DG for emergency…

Read More

A government-appointed task force on Covid-19 on Monday removed plasma therapy from the treatment protocol for adult Covid-19 patients. In the revised clinical guidelines for management of adult Covid-19 patients, use of convalescent plasma therapy has been removed even as an ‘off label treatment. Until now, India’s Covid-19 treatment protocol allowed ‘off label’ use of convalescent plasma therapy but only at the stage of early moderate disease, that is, within seven days of the onset of symptoms, and if there is availability of a high titre donor plasma. The Covid-19 treatment protocol is prepared in consultation with the Indian Council…

Read More

Prof Shahid Jameel, eminent virologist, and head of the advisory group to the Indian SARS-COV-2 Genomics Consortia (INSACOG), resigned from his post on 17th May 2021. The consortia was formed in January 2021, it is doing genomics surveillance of coronavirus in COVID-19 epidemic. It has been tracking international variants of concern as well as discovered the so called ‘Indian variant ‘ (B.1.617) that is believed to be instrumental in India’s devastating second wave. On May 13, in an invited opinion piece for the New York Times, Dr. Jameel summarised India’s response to the multiple waves and the uneven vaccination rollout…

Read More